Notably, although we have shown that verteporfin and CA3 affect the YAP/TEAD signaling pathway in osteosarcoma, we cannot totally exclude that some of the effects of these drugs on cell death and tumor growth are associated with effects independent of the YAP/TEAD pathway. This evidence concerns the gene YAP1 and osteosarcoma.